Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001209191-22-061256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-14 | 2022-12-12 | PCVX | Lukatch Heath | Dir | S - Sale+OE | $43.93 | -335 | 3,444 | -9% | -$14.7K |
| D | 2022-12-14 | 2022-12-12 | PCVX | Lukatch Heath | Dir | M - OptEx | $16.00 | +335 | 3,460 | +11% | +$5,360 |
| D | 2022-12-14 | 2022-12-12 | PCVX | Lukatch Heath | Dir | M - OptEx | $0.00 | -335 | 28.3K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | S | D | 319 | $44.01 | 3,125 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $43.745 to $44.43. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-12-12 | S | D | 16 | $42.37 | 3,444 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-12 | M | A | 335 | $16.00 | 3,460 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2022-12-12 | M | D | 335 | $0.00 | 28,315 | D | $16.00 · — to 2030-06-10 | 335 Common Stock | (F3) 1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter. |